This result may be of particular relevance to ethnic disparities in leukemia patient response to GCs, as alleles that reduce NQO1 enzymatic activity have been associated with decreased response to a chemotherapy regime that included GCs in patients with acute lymphoblastic [51], [52] and acute myeloid leukemia [53]. Here, NQO1 is linked to acute myeloid leukemia.